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The understanding of pluripotent stem cells at a molecular level and progress toward applying these cells to tackle
human disease are advancing at a rapid pace. This Select, coauthored by Cell Editorial Board member Shinya
Yamanaka and Cell Scientific Editor Karen Carniol, highlights recent work at the frontiers of stem cell research.Teratomas formed from Tet1-depleted
ESCs contain an excess of glandular
cells (purple). These are arranged in
a ductal structure next to a necrotic
region (red) within the teratoma. Image
courtesy of Kian Koh.TET-eringbetweenPluripotencyandDifferentiation
There’s a new kid on the block of epigenetic marks, and several recent papers
indicate that it plays an important role in maintaining the balance between pluripo-
tency and lineage commitment. The new player, 5-hydroxymethylcytosine (5hmC),
is an oxidized derivative of the classic DNAmark, 5-methylcytosine (5mC), generated
by the TET enzymes. Now, Wu et al. (2011), Ficz et al. (2011), Williams et al. (2011),
Xu et al. (2011), and Pastor et al. (2011) provide genome-wide views of 5hmC’s distri-
bution in mouse embryonic stem cells (mESCs) and find that it is largely associated
with promoter regions and gene bodies and, depending on the context, can be asso-
ciated with either active or repressed transcription states. TET depletion influences
5hmC levels and gene expression patterns. According to Ficz et al., TET deficiency
reduces expression of several pluripotency-related genes while facilitating the
expression of endoderm markers. Consistent with this, Koh et al. (2011) report that
TET levels are high in pluripotent cells and decline during differentiation. These
changes appear to be regulated directly by the Oct4-Sox2 complex, a core transcrip-
tional mediator of pluripotency, and depletion of TET genes skews lineage specifica-
tion from its normal balance of endoderm, mesoderm, and ectoderm during differen-tiation of mESCs. Thus, 5hmC and the TET enzymes are emerging as key dynamic regulators of pluripotency and
differentiation. This knowledge may be useful in ongoing endeavors to direct pluripotent cells to specific cell types.
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omyocytes express marker proteins of
the heart, such as Troponin T (red), the
striated pattern of which is a hallmark
of differentiated cardiac muscle. Cell
nuclei were visualized with DAPI (blue).
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One such example of directed differentiation that hasmade great progress recently is
the generation of cardiomyocytes. Now, Kattman et al. (2011) have optimized cardi-
omyocyte differentiation from mouse and human pluripotent stem cells (PSCs).
Building on previous work in in vitro systems and embryonic development, the
authors establish a marker for cardiac mesoderm, PdfgR-a, which in combination
with the known Flk-1/KDRmarker, identifies mesodermal cells primed for cardiomyo-
cyte differentiation more robustly than either marker alone. Manipulating the Activin/
Nodal and BMP signaling pathways induces the cardiac mesoderm, but importantly,
the authors find that the stage at which the pathways need to be manipulated and the
concentrations of pathway components required for maximal cardiovascular meso-
derm vary between cell lines. The findings suggest that endogenous pathway compo-
nents must be considered in the generation of specific cell types from PSCs.
An alternative approach to generating specific cell types in vitro is to reprogram
a differentiated cell, such as a fibroblast, directly to the cell type of interest. This is
the strategy taken by Efe et al. (2011) to produce cardiomyocytes, though with an
interesting twist: the factors that they apply to the fibroblasts are those employed
to generate induced pluripotent stem cells (iPSCs). In general, expression of Oct4,
Sox2, Klf4, and c-Myc in mouse fibroblasts induces a pluripotent state, but when Efe et al. transiently express these factors
and remove the cytokine leukemia inhibitory factor (LIF) from the culture media, the cells pass through state in which they
produce cardiac precursor markers. Tweaking culture conditions at key times and ultimately adding BMP triggers efficient
transdifferentiation to beating cardiomyocytes. A number of additional experiments strongly suggest that a pluripotent inter-
mediate is not involved in the transdifferentiation program.More recently, Kim et al. (2011) applied this approach to reprogramCell 145, June 10, 2011 ª2011 Elsevier Inc. 805
fibroblasts directly into expandable neural precursor cells. It will be exciting to see what other cell types can be directly pro-
grammed starting with the iPSC-inducing factors.
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chyme. Image courtesy of Jason Spence.Pluripotent Cells Go 3D
Efficient generation of specific cell types in vitro has tremendous therapeutic poten-
tial, and of equal excitement is the generation of complex tissues in culture. Remark-
able progress has been made on this front, as highlighted by two recent papers. First,
Spence et al. (2011) succeed in generating three-dimensional (3D) intestinal tissue
in vitro starting from human PSCs. Administration of developmental signaling factors
at particular stages of culturing led first to definitive endoderm and then to the hindgut
lineage with markers for intestinal tissue. The flat sheets of cells then spontaneously
form tubes, which bud to release gut tissue spheroids. When the authors transfer
these spheroids to a 3D matrigel culture that is known to support intestinal growth
from tissue-specific progenitor cells, the spheroids undergo morphogenesis reminis-
cent of that seen in fetal gut development. This culminates in the formation of
columnar epithelia with specialized structures and cell types that are characteristicof intestine, such as villi, enterocytes with functional peptide transport systems, mucin-producing cells, and progenitor cell
niches. The authors took advantage of this in vitro organogenesis to test whether the NEUROG3 gene is responsible for
a congenital disorder defined by loss of enteroendocrine cells. Leveraging the system for transplantation-based therapies
is also a tantalizing potential application of this system. Another notable achievement in generating complex 3D tissues in vitro
was reported by Eiraku et al. (2011), who used a 3D culturing system to generate a complex retinal tissue, the optic cup, from
mouse embryonic stem cells, as described in the Select on Vision in the April 29th issue of Cell.
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from the fibroblasts of a patient diag-
nosed with schizophrenia. The neurons
express bIII-tubulin (red) and the den-
dritic marker MAP2AB (green). Nuclei
are visualized with DAPI (blue). Image
courtesy of Kristen Brennand.Taking on Complex Disease with iPSCs
The potential of stem cells lies not only in the ability to generate complex cell types
and tissues, but also in their ability to allow us to study human phenotypes at
a molecular level in human cells without the potentially confounding differences
between humans and model organisms. iPSCs have been derived from the fibro-
blasts of patients with several disorders and then have been effectively differentiated
to create cellular models of the corresponding disease. While most of these studies
have focused on monogenic disorders, Brennand et al. (2011) take a bold step by
establishing a patient iPSC-based model of the complex neuropsychiatric disorder
schizophrenia. They differentiate iPSCs from four schizophrenia patients to neurons
and then characterize the neurons’ gene expression and ability to make synaptic
connections. The patient-derived neurons exhibit reduced connectivity compared
to controls. Expression profiles of these patient-derived neurons are consistent
with this observation, as they show changes in genes associated with forming
synaptic connections, such those in the gluatamate, cAMP, and Wnt signaling
pathways. Approximately one-quarter of the genes with altered expression had
been previously associated with schizophrenia, and the drug loxapine, which is
prescribed for this disorder, ameliorates the defects in synaptic connectivity. The
expression profiling also suggests that pathways not previously associated with
schizophrenia might be important players, such as Notch signaling, cell adhesion,
and Slit/Robo axon guidance. The authors postulate that follow-up studies, including
those with larger numbers of patient-derived neurons, will reveal a core set of pathways and/or genes common to all
patients, hopefully enabling a focused mechanistic dissection and therapeutic targeting effort for this debilitating disease.
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